Concepedia

Publication | Open Access

A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases

69

Citations

29

References

2015

Year

Abstract

For selected patients with liver metastases, single-fraction SABR at doses of 35 and 40 Gy is tolerable and shows promising signs of efficacy at intermediate follow-up.

References

YearCitations

Page 1